Goldman Sachs
PROF

Goldman Sachs’s Profound Medical PROF Stock Holding History

Goldman Sachs’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$121K Sell
18,171
-536
-3% -$3.6K ﹤0.01% 6309
2026
Q1 		$121K Sell
18,707
-20
-0.1% -$138 ﹤0.01% 6183
2025
Q4 		$147K Buy
18,727
+6,787
+57% +$43.6K ﹤0.01% 6120
2025
Q3 		$58.4K Buy
11,940
+345
+3% +$1.76K ﹤0.01% 6154
2025
Q2 		$68.4K Buy
+11,595
New +$61.3K ﹤0.01% 5879
2024
Q2 		– Sell
-16,700
Closed -$142K – 5865
2024
Q1 		$142K Sell
16,700
-5,500
-25% -$45.9K ﹤0.01% 5190
2023
Q4 		$188K Buy
22,200
+2,800
+14% +$26.6K ﹤0.01% 5171
2023
Q3 		$198K Buy
19,400
+2,700
+16% +$28K ﹤0.01% 5047
2023
Q2 		$217K Buy
+16,700
New +$207K ﹤0.01% 5149

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $349M AUM 28.06% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $476M AUM
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Goldman Sachs's PROF Position: Q2 2026 in Review

Goldman Sachs reduced its Profound Medical (PROF) stake by 2.9% in Q2 2026, selling an estimated $3.6K and leaving 18,171 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #6309.

Goldman Sachs first reported a position in PROF in Q2 2023 and has held it in 9 quarters since. The position peaked at $217K in Q2 2023. 56 funds tracked by Wall St. Rank hold PROF as of Q2 2026.

  • Goldman Sachs held 18,171 shares of Profound Medical worth $121K as of Q2 2026.
  • Goldman Sachs sold 536 Profound Medical shares in Q2 2026, an estimated $3.6K.
  • Profound Medical made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #6309 holding.
  • Goldman Sachs first reported a position in Profound Medical in Q2 2023 and has held it in 9 quarters since.
  • Goldman Sachs's Profound Medical position peaked at $217K in Q2 2023.
  • 56 funds tracked by Wall St. Rank held Profound Medical as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.